145 related articles for article (PubMed ID: 38239938)
21. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
Shin JY; Sohn J; Park KH
J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
[TBL] [Abstract][Full Text] [Related]
22. miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.
Ye EA; Liu L; Steinle JJ
Vision Res; 2017 Oct; 139():23-29. PubMed ID: 28774775
[TBL] [Abstract][Full Text] [Related]
23. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
[TBL] [Abstract][Full Text] [Related]
24. ANGPTL-4 induces diabetic retinal inflammation by activating Profilin-1.
Lu Q; Lu P; Chen W; Lu L; Zheng Z
Exp Eye Res; 2018 Jan; 166():140-150. PubMed ID: 29031854
[TBL] [Abstract][Full Text] [Related]
25. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
26. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
[TBL] [Abstract][Full Text] [Related]
27. Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature.
Jiang Y; Liu L; Steinle JJ
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):185-189. PubMed ID: 28114578
[TBL] [Abstract][Full Text] [Related]
28. High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction.
Singh GB; Zhang Y; Boini KM; Koka S
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336567
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
30. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
Elshaer SL; Alwhaibi A; Mohamed R; Lemtalsi T; Coucha M; Longo FM; El-Remessy AB
Diabetologia; 2019 Aug; 62(8):1488-1500. PubMed ID: 31073629
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of co-culture and monoculture models in simulating diabetic neurovascular dysfunction: insights into diabetic retinopathy.
Wang Q; Qiao Z; Kang W; Zhu L; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1215218. PubMed ID: 37745714
[TBL] [Abstract][Full Text] [Related]
33.
Sun ZY; Wang FJ; Guo H; Chen L; Chai LJ; Li RL; Hu LM; Wang H; Wang SX
Neural Regen Res; 2019 May; 14(5):783-793. PubMed ID: 30688264
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting P2Y12 receptor relieves LPS-induced inflammation and endothelial dysfunction.
Han X
Immun Inflamm Dis; 2022 Oct; 10(10):e697. PubMed ID: 36169256
[TBL] [Abstract][Full Text] [Related]
35. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation.
Gonçalves A; Almeida L; Silva AP; Fontes-Ribeiro C; Ambrósio AF; Cristóvão A; Fernandes R
Biomed Pharmacother; 2018 Jun; 102():833-838. PubMed ID: 29605771
[TBL] [Abstract][Full Text] [Related]
36. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
37. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes.
Leal EC; Martins J; Voabil P; Liberal J; Chiavaroli C; Bauer J; Cunha-Vaz J; Ambrósio AF
Diabetes; 2010 Oct; 59(10):2637-45. PubMed ID: 20627932
[TBL] [Abstract][Full Text] [Related]
38. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
39. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.
Díaz-Coránguez M; Lin CM; Liebner S; Antonetti DA
J Biol Chem; 2020 Apr; 295(14):4647-4660. PubMed ID: 32086377
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assembly.
Zhang L; Liu H; Peng YM; Dai YY; Liu FY
Eur Rev Med Pharmacol Sci; 2015; 19(14):2621-7. PubMed ID: 26221892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
